Oyster Point is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat ocular surface disease.

Company Name

Oyster Point Pharmaceuticals

Location

San Francisco, CA

Investment Stage

IPO October 2019